These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
115 related items for PubMed ID: 22398883
1. Genital herpes zoster as a consequence of cancer chemotherapy-induced immunosuppression: report of a case. Gopalan V, Nair RG, Pillai S, Oberholzer T. J Infect Chemother; 2012 Dec; 18(6):955-7. PubMed ID: 22398883 [Abstract] [Full Text] [Related]
2. Genital Herpes Zoster as Possible Indicator of HIV Infection. Ljubojević Hadžavdić S, Kovačević M, Skerlev M, Zekan Š. Acta Dermatovenerol Croat; 2018 Dec; 26(4):337-338. PubMed ID: 30665486 [Abstract] [Full Text] [Related]
3. Clinical course and therapeutic approach to varicella zoster virus infection in children with rheumatic autoimmune diseases under immunosuppression. Leuvenink R, Aeschlimann F, Baer W, Berthet G, Cannizzaro E, Hofer M, Kaiser D, Schroeder S, Heininger U, Woerner A. Pediatr Rheumatol Online J; 2016 Jun 02; 14(1):34. PubMed ID: 27256096 [Abstract] [Full Text] [Related]
4. Incidence of herpes zoster in patients with inflammatory bowel disease. Calm A, Calafat M, González-Muñoza C, Cañete F, Roig C, Mañosa M, García-Planella E, Domènech E. Gastroenterol Hepatol; 2024 Jun 02; 47(6):598-604. PubMed ID: 38316174 [Abstract] [Full Text] [Related]
5. The incidence of recurrent herpes simplex and herpes zoster infection during treatment with arsenic trioxide. Nouri K, Ricotti CA, Bouzari N, Chen H, Ahn E, Bach A. J Drugs Dermatol; 2006 Feb 02; 5(2):182-5. PubMed ID: 16485889 [Abstract] [Full Text] [Related]
6. Risk of Herpes Zoster and Disseminated Varicella Zoster in Patients Taking Immunosuppressant Drugs at the Time of Zoster Vaccination. Cheetham TC, Marcy SM, Tseng HF, Sy LS, Liu IL, Bixler F, Baxter R, Donahue JG, Naleway AL, Jacobsen SJ. Mayo Clin Proc; 2015 Jul 02; 90(7):865-73. PubMed ID: 26051268 [Abstract] [Full Text] [Related]
7. Serological evidence of increased susceptibility to varicella-zoster virus reactivation or reinfection in natalizumab-treated patients with multiple sclerosis. Kohlmann R, Salmen A, Chan A, Knabbe C, Diekmann J, Brockmeyer N, Skaletz-Rorowski A, Michalik C, Gold R, Überla K. Mult Scler; 2015 Dec 02; 21(14):1823-32. PubMed ID: 25828755 [Abstract] [Full Text] [Related]
8. Genital Herpes Zoster: A Rare Location That Can Mimic Genital Herpes. Magdaleno-Tapial J, Hernández-Bel P, Ortiz-Salvador JM, López-Martí C, Martínez-Doménech Á, García-Legaz-Martínez M, Pérez-Ferriols A. Sex Transm Dis; 2022 Jan 01; 49(1):e34-e36. PubMed ID: 33993159 [Abstract] [Full Text] [Related]
9. Clinical and immunologic features of recurrent herpes zoster (HZ). Nakamura Y, Miyagawa F, Okazaki A, Okuno Y, Mori Y, Iso H, Yamanishi K, Asada H, Shozu Herpes Zoster Study Group. J Am Acad Dermatol; 2016 Nov 01; 75(5):950-956.e1. PubMed ID: 27473453 [Abstract] [Full Text] [Related]
10. Providers' lack of knowledge about herpes zoster in HIV-infected patients is among barriers to herpes zoster vaccination. Aziz M, Kessler H, Huhn G. Int J STD AIDS; 2013 Jun 01; 24(6):433-9. PubMed ID: 23970744 [Abstract] [Full Text] [Related]
11. Bortezomib and bilateral herpes zoster. di Meo N, Bergamo S, Dondas A, Trevisan G. Acta Dermatovenerol Alp Pannonica Adriat; 2012 Jun 01; 21(1):21-2. PubMed ID: 22584902 [Abstract] [Full Text] [Related]
12. Varicella-zoster virus infections in patients treated with fingolimod: risk assessment and consensus recommendations for management. Arvin AM, Wolinsky JS, Kappos L, Morris MI, Reder AT, Tornatore C, Gershon A, Gershon M, Levin MJ, Bezuidenhoudt M, Putzki N. JAMA Neurol; 2015 Jan 01; 72(1):31-9. PubMed ID: 25419615 [Abstract] [Full Text] [Related]
13. Successful differentiation of herpes zoster-associated erythema multiforme from generalized extension of herpes by rapid polymerase chain reaction analysis. Kasuya A, Sakabe J, Kageyama R, Ikeya S, Fujiyama T, Tokura Y. J Dermatol; 2014 Jun 01; 41(6):542-4. PubMed ID: 24909215 [Abstract] [Full Text] [Related]
14. Frequent varicella zoster reactivation associated with therapeutic use of arsenic trioxide: portents of an old scourge. Au WY, Kwong YL. J Am Acad Dermatol; 2005 Nov 01; 53(5):890-2. PubMed ID: 16243151 [Abstract] [Full Text] [Related]
15. Analysis of herpes zoster events among bortezomib-treated patients in the phase III APEX study. Chanan-Khan A, Sonneveld P, Schuster MW, Stadtmauer EA, Facon T, Harousseau JL, Ben-Yehuda D, Lonial S, Goldschmidt H, Reece D, Neuwirth R, Anderson KC, Richardson PG. J Clin Oncol; 2008 Oct 10; 26(29):4784-90. PubMed ID: 18711175 [Abstract] [Full Text] [Related]
16. Transmission of varicella zoster virus from individuals with herpes zoster or varicella in school and day care settings. Viner K, Perella D, Lopez A, Bialek S, Newbern C, Pierre R, Spells N, Watson B. J Infect Dis; 2012 May 01; 205(9):1336-41. PubMed ID: 22454467 [Abstract] [Full Text] [Related]
17. Immunosuppressive medication use and risk of herpes zoster (HZ) in patients with systemic lupus erythematosus (SLE): A nationwide case-control study. Hu SC, Yen FL, Wang TN, Lin YC, Lin CL, Chen GS. J Am Acad Dermatol; 2016 Jul 01; 75(1):49-58. PubMed ID: 26946984 [Abstract] [Full Text] [Related]
18. Incidence and Prevention of Herpes Zoster Reactivation in Patients with Autoimmune Diseases. Chakravarty EF. Rheum Dis Clin North Am; 2017 Feb 01; 43(1):111-121. PubMed ID: 27890168 [Abstract] [Full Text] [Related]
19. Herpes zoster ophthalmicus natural history, risk factors, clinical presentation, and morbidity. Liesegang TJ. Ophthalmology; 2008 Feb 01; 115(2 Suppl):S3-12. PubMed ID: 18243930 [Abstract] [Full Text] [Related]